Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
Want to see BRNS full AI Analyst Report?
Technical Sentiment
Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Barinthus Biotherapeutics’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Barinthus Biotherapeutics is a Buy.
Barinthus Biotherapeutics’s (BRNS) 20-Day exponential moving average is 0.65, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Buy.
Barinthus Biotherapeutics’s (BRNS) 50-Day exponential moving average is 0.64, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Buy.
Barinthus Biotherapeutics (BRNS) Pivot Points
Classic
0.54
0.59
0.61
0.66
0.68
0.73
0.76
Fibonacci
0.59
0.62
0.63
0.66
0.69
0.70
0.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Barinthus Biotherapeutics (BRNS) Moving Averages
MA5
0.68Buy
0.67Buy
MA10
0.68Buy
0.67Buy
MA20
0.66Buy
0.65Buy
MA50
0.61Buy
0.64Buy
MA100
0.65Buy
0.68Sell
MA200
0.87Sell
0.85Sell
Barinthus Biotherapeutics’s (BRNS) 10-Day exponential moving average is 0.67, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Buy.
Barinthus Biotherapeutics’s (BRNS) 100-Day exponential moving average is 0.68, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 50-day simple moving average is 0.61, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 100-day simple moving average is 0.65, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 200-day simple moving average is 0.87, creating a Sell signal.
Barinthus Biotherapeutics (BRNS) Technical Indicators
RSI (14)
56.30
Neutral
STOCH (9,6)
36.61
Neutral
STOCHRSI (14)
52.78
Neutral
MACD (12,26)
0.02
Buy
ADX (14)
37.21
Neutral
Williams %R
-41.67
Buy
CCI (14)
81.36
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
43.76
Neutral
ROC
13.33
Buy
Barinthus Biotherapeutics’s (BRNS) Relative Strength Index (RSI) is 56.30, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Trend Strength Indicator (ADX) is 37.21, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Commodity Channel Index (CCI) is 81.36, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Price Rate of Change (ROC) is 13.33, creating a Buy signal.
FAQ
Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Buy.
What is BRNS’s RSI (14)?
BRNS’s RSI (14) is 56.30, which suggests BRNS is a Neutral.
What is BRNS’s MACD?
BRNS’s MACD is 0.02, which suggests BRNS is a Buy.
What is BRNS’s 5-day moving average?
BRNS’s 5-day moving average is 0.68, which suggests BRNS is a Buy.
What is BRNS’s 20-day moving average?
BRNS 20-day moving average is 0.66, which suggests BRNS is a Buy.
What is BRNS’s 50-day moving average?
BRNS’s 50-day moving average is 0.61, which suggests BRNS is a Buy.
What is BRNS’s 200-day moving average?
BRNS’s 200-day moving average is 0.87, which suggests BRNS is a Sell.
What is BRNS’s Williams % R (14)?
BRNS’s Williams % R (14) is -41.67, which suggests BRNS is a Buy.
What is BRNS’s CCI (14)?
BRNS’s CCI (14) is 81.36, which suggests BRNS is a Neutral.